SAN DIEGO, Jan. 8, 2026 /PRNewswire/ -- Aspen Neuroscience, Inc., a clinical‑stage biotechnology company pioneering autologous regenerative therapies, today announced completion of Cohort Three* ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results